# Council Regulation (EU) No 557/2014 of 6 May 2014 establishing the Innovative Medicines Initiative 2 Joint Undertaking (Text with EEA relevance), Division 2: The Governing Board shall hold its ordinary meetings at least twice a year. It may hold extraordinary meetings at the request of any Member or at the request of the chairperson. The meetings of the Governing Board shall be convened by its chairperson and shall normally take place at the seat of the IMI2 Joint Undertaking.

Extent: E+W+S+N.I.

The Executive Director shall take part in the deliberations, but shall have no voting rights.
The Governing Board shall invite any Associated Partner to take part in deliberations of the Governing Board for those points on the agenda that concern its association. Associated Partners shall have no voting rights.
The chairperson of the States Representatives Group shall attend meetings of the Governing Board and take part in the deliberations but shall have no voting rights.
The chairperson of the Scientific Committee shall have the right, whenever issues falling within its tasks are discussed, to attend meetings of the Governing Board as an observer and take part in its deliberations, but shall have no voting rights.
The Governing Board may invite, on a case-by-case basis, other persons to attend its meetings as observers, in particular representatives of regional authorities within the Union.

---
Source: https://www.legislation.gov.uk/eur/2014/557/annex/division/6/division/2 (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-557/annex/division-6/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.